THOMPSON DAVIS & CO., INC. - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 75 filers reported holding DURATA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.75 and the average weighting 0.6%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$3,0000.0%2500.0%0.00%
-20.0%
Q1 2014$3,0002500.01%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders